Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial—EPOC 2 (JFMC49-1601-C5)

BACKGROUND: Oral mucositis (OM) is an unpleasant adverse event in patients receiving chemotherapy. A prospective feasibility study showed that elemental diet (ED), an oral supplement that does not require digestion, may prevent OM. Based on this, we established a central review system for oral cavit...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Y., Takeuchi, H., Nakashima, Y., Nagano, H., Ueno, T., Tomizuka, K., Morita, S., Emi, Y., Hamai, Y., Hihara, J., Saeki, H., Oki, E., Kunisaki, C., Otsuji, E., Baba, H., Matsubara, H., Maehara, Y., Kitagawa, Y., Yoshida, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511839/
https://www.ncbi.nlm.nih.gov/pubmed/34626918
http://dx.doi.org/10.1016/j.esmoop.2021.100277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511839/
https://www.ncbi.nlm.nih.gov/pubmed/34626918
http://dx.doi.org/10.1016/j.esmoop.2021.100277

Ejemplares similares